This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

  1. Tool
  2. Source: Campus Sanofi
  3. 24 Feb 2025
1 min

Asthma AAC Tool

Author: Sanofi

Editorial Team

Prescribing Information UK

asthma-aac-tool
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

The Accelerated Access Collaborative (AAC) Consensus Pathway was produced to provide a set of standards for the care of adults with uncontrolled and severe asthma based on best practice. It is intended to guide clinicians, managers and commissioners on what optimal care should look like across the entire patient journey to reach improvements in outcomes. The AAC asthma biologics programme is led by Oxford AHSN on behalf of the AHSN Network.

                                                                   

Learn more about Dupixent (dupilumab) for your patients

MAT-XU-2402677 (v2.0) Date of Preparation: February 2025